Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CBiPES is a positive allosteric modulator (PAM) of metabotropic glutamate receptor 2 (mGluR2).1 It selectively enhances glutamate-induced increases in intracellular calcium levels in mGluR2-expressing MCB3901 cells (EC50 = 92.8 nM) over those expressing other mGluR subtypes at 30 µM. CBiPES decreases stress-induced hyperthermia in a mouse model of anxiety and reduces spontaneous locomotor activity and PCP-induced hyperlocomotor activity in mice. It inhibits ketamine-induced histamine release in the medial prefrontal cortex in rats at 60 mg/kg.2 CBiPES (1 and 10 mg/kg) decreases L-DOPA- and benserazide-induced dyskinesia, psychosis-like behaviors, and parkinsonism in a marmoset model of MPTP-induced Parkinson’s disease.3
WARNING This product is not for human or veterinary use.
1. Metabotropic glutamate 2 receptor potentiators: Receptor modulation, frequency-
2. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge. Neuropharmacology 58(3), 632-639 (2010).
3. Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-